Keyword: Medivation

David Hung

3. David Hung

In 2016, David Hung parlayed Medivation’s prostate cancer med Xtandi and its pipeline, including PARP inhibitor talazoparib, into a $14 billion sale to Pfizer.
Person offering money

The top 15 highest-paid biopharma executives

Some of the executive pay rankings are predictable, like Johnson & Johnson's CEO, regardless who's in the job. What's not guaranteed is that the chairman of a generics maker in hot water with the U.S. government and American parents—Mylan's Robert Coury—would step off the company’s employee roster and into the nonexecutive chairman’s job and reap a $97 million package with the move.